Understanding IBMPFD: Muscle, Bone, and Brain Disease
This study is looking into a genetic condition called IBMPFD (Inclusion Body Myopathy with Paget's Disease of Bone and Frontotemporal Dementia). This condition causes problems with muscles, bones, and thinking, and is linked to changes in the VCP gene. Researchers want to understand how these VCP gene changes lead to these health issues. You may be able to join if you or your family have a history of muscle disease (myopathy), bone disease (Paget's disease), or dementia (frontotemporal dementia), even if you don't have all these symptoms. The study aims to enroll 50 participants. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will collect information without providing any specific treatments. It aims to include 50 participants.
- What's involved
- Participants will provide biological samples like blood and urine, share their family and medical histories, and complete questionnaires.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Characterization of Inclusion Body Myopathy Associated With Paget's Disease of Bone and Frontotemporal Dementia (IBMPFD)
At a glance
A primary outcome measure isn't published for this study.
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Virginia Kimonis, MD · PRINCIPAL_INVESTIGATOR · University of California, Irvine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.